Patients Characteristics | Overall population (N =390) | Cohort set 1 (N =192) | Cohort set 2 (N =198) | P | ||||
---|---|---|---|---|---|---|---|---|
N | N | N | ||||||
Pre-operative parameters | Age at surgery — years | 390 | 192 | 198 | ||||
≤ 65 | 174 (45 %) | 87 (45 %) | 87 (44 %) | |||||
> 65 | 216 (55 %) | 105 (55 %) | 111 (56 %) | 0.8387 | ||||
Patient male sex — no. (%) | 390 | 222 (57 %) | 192 | 103 (54 %) | 198 | 119 (60 %) | 0.2201 | |
Diabetes — no. (%) | 325 | 186 | 139 | |||||
No | 252 (78 %) | 143 (77 %) | 109 (78 %) | |||||
Yes | 73 (22 %) | 43 (23 %) | 30 (22 %) | 0.7891 | ||||
Albuminemia g/L | 191 | 36.4 ± 7.7 | 70 | 32.6 ± 6.4 | 121 | 38.6 ± 7.4 | <0.0001 | |
Tumor Size in cm | 301 | 3.8 ± 1.6 | 164 | 3.6 ± 1.5 | 137 | 4.0 ± 1.6 | 0.0095 | |
Tumoral post-operative parameters | pT Local invasion — no. (%) | 375 | 184 | 193 | ||||
0-1-2 | 39 (10 %) | 28 (15 %) | 11 (6 %) | |||||
3–4 | 336 (90 %) | 154 (85 %) | 182 (94 %) | 0.0022 | ||||
N status | 388 | 190 | 198 | |||||
0 | 119 (31 %) | 68 (36 %) | 51 (26 %) | |||||
1 | 269 (69 %) | 122 (64 %) | 147 (74 %) | 0.0365 | ||||
Positive lymph nodes ratio | 380 | 0.15 ± 0.19 | 182 | 0.20 ± 0.23 | 198 | 0.12 ± 0.14 | <0.0001 | |
Lymph Nodes ratio | ||||||||
< 0.2 | 380 | 279 (73 %) | 117 (64 %) | 162 (81 %) | ||||
≥ 0.2 | 104 (27 %) | 67 (36 %) | 37 (19 %) | <0.0001 | ||||
Histological Grade | 331 | 160 | 171 | |||||
Poorly differentiated | 85 (26 %) | 23 (14 %) | 62 (36 %) | |||||
Moderately differentiated | 158 (48 %) | 76 (48 %) | 82 (48 %) | |||||
Well differentiated | 88 (26 %) | 61 (38 %) | 27 (16 %) | <0.0001 | ||||
Vascular invasion | 361 | 186 | 175 | |||||
No | 242 (67 %) | 115 (62 %) | 127 (73 %) | |||||
Yes | 119 (33 %) | 71 (38 %) | 48 (27 %) | 0.0335 | ||||
Lymphatic invasion | 364 | 189 | 175 | |||||
No | 230 (63 %) | 107 (57 %) | 123 (70 %) | |||||
Yes | 134 (37 %) | 82 (43 %) | 52 (30 %) | 0.0089 | ||||
Perineural invasion | 365 | 191 | 174 | |||||
No | 138 (38 %) | 57 (30 %) | 81 (47 %) | |||||
Yes | 227 (62 %) | 134 (70 %) | 93 (53 %) | 0.0012 | ||||
Therapeutic post-operative parameter | Adjuvant Chemotherapy | 336 | 251 (75 %) | 183 | 118 (64 %) | 153 | 133 (87 %) | <0.0001 |
Lymphopenia parameters | Pre-operative lymphocyte counta | 390 | 1458.9 (150–8350) | 194 | 1492.1 (170–3052) | 199 | 1426 (150–8350) | 0.3362 |
Post-operative lymphocyte counta | 299 | 1410 (200–32000) | 127 | 1400 (251–3620) | 172 | 1430 (200–32000) | 0.2657 | |
Follow-up parameters | Death events | 393 | 309 (79 %) | 192 | 157 (82 %) | 198 | 152 (77 %) | 0.2233 |
Median F-up time in months 95 % CIb | 66.6 (60.8–78.7) | 66.6 (58.0–84.0) | 67.2 (56.2–79.0) |